• Events Calendar
    • Cell & Gene
    • Oligonucleotides
    • Peptides
    • Proteins, Antibodies & ADCs
    • Vaccines
    • Drug Discovery
    • Drug Development
    • Manufacturing & Production
    • Commercialisations & Supply Chain
    • News
    • Market Insight
    • Thought Leadership
    • Technology Spotlight
  • About Us
Register Sign In
  • Events Calendar
  • Therapeutic Modality
      Cell & Gene
      Oligonucleotides
      Peptides
      Proteins, Antibodies & ADCs
      Vaccines
  • Pipeline Stage
      Drug Discovery
      Drug Development
      Manufacturing & Production
      Commercialisations & Supply Chain
  • Format
      News
      Market Insight
      Thought Leadership
      Technology Spotlight
  • About Us
    Search
Sign In
Thought Leadership Vaccines Manufacturing & Production

What's Next for LNP Vectors and mRNA Vaccines?

On-Demand
April 9, 2025
|
08:00 UK Time
|
Event lasts 1h
Yuji Kasuya

Yuji Kasuya

Senior Scientist

Daiichi Sankyo

Format: 20 minute presentation followed by 40 minute panel discussion

Register free to attend thought leadership

Do you have a question you’d like Yuji Kasuya to answer during the session?

Register and ask
Related posts
Development of Personalised Cancer Vaccines

Development of Personalised Cancer Vaccines

Elisa Scarselli Nouscom
Vaccines
Apr, 2025
What's Next for LNP Vectors and mRNA Vaccines?

What's Next for LNP Vectors and mRNA Vaccines?

Yuji Kasuya Daiichi Sankyo
Vaccines
Apr, 2025
Upcoming events
02
Jul
Bioanalytical Challenges in Complex Biologics

Online

The session will begin with a featured interview with Dr. Anka Ehrhardt, Director of Cell-Based Sciences at Merck, offering her insights on the current bioanalytical challenges associated with complex biologics. Followed by a 30-minute panel discussion

02
Oct
Biologics US 2025

In-Person

Biologics US 2025 brings together leaders in biologics R&D through two focused programs on one dynamic platform. Over two immersive days, the event spotlights breakthrough innovations in proteins, antibodies, and the development of antibody-drug conjugates (ADCs).

Register for free to view

  • Quickly grasp the key takeaways from cutting-edge biomed research with our bite-sized 5-minute video summaries, before diving into the full presentations from leaders in the industry.

  • From cutting-edge discoveries to real-world applications, see how new research can impact your work, from the lab to commercialisation.

  • Join a community of next-gen scientists, academics and researchers, stay connected, and engage with the latest innovations shaping the future of biomedicine.

Register Free

Already registered? Sign In.

  • Events
    About Us
    Contact Us
    FAQ
    Privacy Policy
    Terms and Conditions
    Cookie Policy
    Manage Cookies
  • Cell & Gene
    Oligonucleotides
    Peptides
    Proteins, Antibodies & ADCs
    Vaccines
  • Drug Discovery
    Drug Development
    Manufacturing & Production
    Commercialisation & Supply Chain
  • News
    Market Insight
    Technology Spotlight
    Thought Leadership
  • Discovery & Development
    NextGen Biomed
    Precision Medicine
    Oxford Global
© 2025 Oxford Global Ltd. All rights reserved.
Designed & built by Standfirst

You're just a click away

To access our site, please accept the Terms of Use - our full terms of use are available below.
Full Terms of Use

By rejecting you won't be able to progress to the LifeScienceXchange platform.